DELETERIOUS BRCA1 GENE MUTATION
Clinical trials for DELETERIOUS BRCA1 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new DELETERIOUS BRCA1 GENE MUTATION trials appear
Sign up with your email to follow new studies for DELETERIOUS BRCA1 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets recurrent ovarian and endometrial cancers
Disease control OngoingThis early-phase study tests a combination of two oral and intravenous drugs (niraparib and copanlisib) in people whose endometrial, ovarian, peritoneal, or fallopian tube cancer has returned. The main goal is to find the safest dose and understand side effects. About 31 particip…
Matched conditions: DELETERIOUS BRCA1 GENE MUTATION
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:13 UTC
-
Hunger training may cut breast cancer risk in obese women
Prevention OngoingThis pilot study looks at whether adding hunger training to a standard diabetes prevention program helps obese women at high risk for breast cancer lose weight and potentially lower their cancer risk. About 51 participants will learn weight-loss strategies and how to recognize tr…
Matched conditions: DELETERIOUS BRCA1 GENE MUTATION
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated May 22, 2026 13:54 UTC
-
Can a less invasive surgery prevent ovarian cancer without harming sexual health?
Prevention OngoingThis study looks at two types of surgery to prevent ovarian cancer in women with certain gene mutations (like BRCA). One surgery removes both ovaries and fallopian tubes, while the other removes only the fallopian tubes first and delays ovary removal. The goal is to see which app…
Matched conditions: DELETERIOUS BRCA1 GENE MUTATION
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated May 22, 2026 13:53 UTC